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Summary: Recently much evidence has accumulated indicating that oxidative modification of atherogenic lipopro-
teins plays an important role in atherogenesis. The goal of this study was to ascertain whether any association exists
between this and the previously incriminated risk factors of atherosclerotic cardiovascular disease like age, gender
and cholesterol concentration.
Serum lipid profile, low-density lipoprotein (LDL) composition and indicators of LDL oxidation were examined in
a cohort of healthy, predominantly middle aged men and women. LDL oxidation was assessed using the copper
catalysis method, and monitored routinely by the increase in conjugated dienes over 4 to 24 hours. A more objective
computer-aided technique was used to estimate the oxidative indices based on the sigmoidal fit to data.
No marked differences between men and women were found with respect to mean age, total and LDL cholesterol,
LDL protein and oxidation of LDL.
The post-menopausal as compared to pre-menopausal status was associated with a greater extent of LDL oxidation,
as well as with higher total serum cholesterol and its fractions, LDL cholesterol and LDL protein. No such differ-
ences were found in the data for men appropriately separated according to age.
In a group with high risk LDL cholesterol, the total LDL oxidation was higher, as well as age and total cholesterol.
Lag time and half-time of LDL oxidation were significantly shorter, while the oxidation rate of LDL was signifi-
cantly faster when compared with data in the lower quartile.
About six percent of participants had a considerably prolonged initial oxidation phase. These persons also showed
low total and LDL cholesterol. High oxidation resistance was reversible and most probably caused by very low
pre-existent oxidation products.
Multiple regression analysis showed that the closest association among age, gender, lipid profiles and LDL oxidation
indices existed between LDL cholesterol and conjugated diene production in both sexes (men: r = 0.93; women:
r = 0.81). This association remained high even if adjusted for age.
As in earlier epidemiological studies using logistic regression and showing age- and gender-related rising frequency
of coronary heart disease, the present paper demonstrated age- and gender-related rising frequency of highly oxi-
dized LDL. In both cases it was closely associated with an increasing LDL cholesterol concentration.
Introduction is known about the oxidized LDL turnover rate, and
-r, . _ . . ι · j Λ. 4. · j· j ι many other questions remain unanswered (3, 52).There is strong experimental evidence that oxidized low- J n v '
density lipoproteins (oxidized LDL) play an important The incidence of coronary artery disease increases mark-
role in atherogenesis. Above all, and in contrast to native
 edly with age in both men and women. Age, gender and
LDL, they are recognizable by the non down-regulating menopausal status are major genetic risk factors for cor-
macrophage scavenger receptor, resulting in the forma- onary artery disease, while the cholesterol concentration,
tion of foam cells characteristic of early-stage athero- diet and lifestyle are largely environmental risk factors
sclerosis (1,2). The site and mode of endogenous oxi- in an otherwise healthy population (4-6).
dized LDL formation has not been identified as yet, little
In our previous study, we found a close association be-
tween cholesterol concentration and the extent of LDL
') The work was supported by a grant of the Ministry of Health, oxidation, whereas the effects of age or gender were of
Prague, Czech Republic marginal significance (7).
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This paper aims to evaluate data from a new cohort of
the population with a broader age range. The effects of
age, gender and menopausal status on the LDL oxidation
indices became evident, and the development of high
oxidized LDL formation was demonstrated using logis-
tic regression.
Materials and Methods
Randomly sampled human sera from 104 healthy, predominantly
blood donor volunteers (52 men and 52 women) were used fresh
or stored at + 2 °C no longer than 3 days. Since the results ob-
tained with fresh or stored sera did not differ appreciably, and se-
rum is known to contain abundant endogenous antioxidants, these
were not added in excess except after precipitation and redissolu-
tion of isolated LDL.
All the reagents, specific inhibitors and lipid substrates used were
of reagent grade and were purchased from Sigma Chemical Com-
pany (St. Louis, Mo, USA), Merck (Darmstadt, Germany) and
Lachema (Brno, Czech Republic).
Commercial kits for the enzymatic determination of cholesterol in
serum were from Lachema-Diagnostica (Brno, CR). Cholesterol in
isolated LDL was determined by the same method, but using a
proportionately greater volume than that for the measurement of
serum cholesterol and treating the standard cholesterol solution in
the same way.
Precipitation reagent for LDL isolation (cat. No. 14992) was from
Merck (Darmstadt, Germany).
Physiological salt solution was Krebs-Henseleit buffer containing
(in mmol/1): 118 NaCl, 4.7 KC1, 1.2 KH2PO4, 2.5 MgSO4, 25
NaHCO3, 11 glucose, and 1 CaEDTA and saturated with 95% O2
plus 5% CO2.
Protein content was measured as described by Bradford (8) and
verified by the Lowry method (9) and optical absorbance at 210
and/or 280 run. No interference with any component of Merck's
precipitation reagent in the expected concentration range was
found.
Preparation of low-density lipoprotein
A rapid precipitation technique convenient for serial assays was
preferred. It was based on the formation of a complex of heparin
with LDL at an isoelectric point. An almost perfect correlation with
ultracentrifugation or quantitative electrophoresis was found (10).
The precipitation technique considerably shortens the pre-oxidative
preparation of LDL. Moreover, it is believed that the complexed
LDL is structurally similar to the LDL that exists in vivo after
entering the arterial wall and binding to the arterial glucosamino-
glycans (11-14).
Briefly, LDL isolation was carried out according to the manufac-
turer's instructions (Merck) by mixing in a centrifugation tube with
a conical bottom, 0.5 ml of serum with 5 ml of precipitation solu-
tion at laboratory temperature, followed by 10 min standing, then
centrifugation at 2000 g for 10 min. The supernatant was discarded.
The inner wall of the tube with the open end turned down was
thoroughly washed just above the precipitate to completely remove
the residues of serum and precipitation solution, using a micropi-
pette connected to a redistilled water reservoir.
The precipitate of LDL was dissolved in 10ml of warm Krebs-
Henseleit solution (37 °C) with slow and gentle stirring of the pre-
cipitate with a tiny glass rod. Thus, the final concentration of a
clear solution of LDL was 20 times lower than its original serum
concentration. Reproducibility of the method was found to be satis-
factory with a variation coefficient of about 7%.
The analysis (protein, cholesterol) and subsequent experiments
with isolated LDL were started immediately.
Oxidative modification of low-density lipoproteins
From several available methods, the most frequently used copper-
induced oxidation method was chosen (1). Briefly, 2.5 ml of LDL
samples and copper sulphate at a final concentration of 10 μηιοΐ/l
(routine assay) were mixed directly in photometry quartz cuvettes
(1 X 1 cm), closed and incubated for 4—24 h at 37 °C in a water
bath. The formation of conjugated dienes was monitored every
15—30 minutes according to Esterbauer (15). Both wavelength
scanning between 220 and 300 nm and multiwavelength photome-
try close to the absorbance peak were used. Peak differential absor-
bance was close to 234 nm.
The absorbance units were recalculated to conjugated dienes using
a molar absorbance coefficient ε of 2950m2/mol (16).
The kinetics of Cu2+-catalysed oxidation of LDL were similar to
those of LDL isolated by ultracentrifugation (7, 16). On the other
hand the correct quantitative comparison of oxidative indices in
both methods was very difficult in the absence of any standardized
method. For instance the oxidation lag time of LDL isolated ultra-
centrifugally could vary from 15 min (17) to 242 min (18) and
reported times also vary in the same publication, using the same
isolation technique. The reason is the notorious instability of iso-
lated LDL and its unexpected sensitivity to various manipulations.
Statistical analysis
Data are expressed as means ± SD, and N refers to the number of
analysed individual serum samples. ANOVA and t-tests were used
to evaluate the statistical significance of differences. A two-tailed
probability value P < 0.05 was considered to be statistically signif-
icant. Quantities of LDL oxidation kinetics were calculated from
the sigmoidal fit (Borland) to experimental data. The obtained
primitive regression functions permit the easy calculation of their
first or higher order derivatives, which enable a more objective
demonstration of some analytical results. These and other statistical
tests, correlation coefficients and regression parameters were cal-
culated using computer-aided programs (ORIGIN, MicroCal Soft-
ware Inc., STATISTICA, Statsoft and EXCEL, Microsoft).
Results
Basic characteristics and stratification
analysis of examined group
a) Most participants in the study were voluntary blood
donors without any manifest disease or abnormal life-
style. Average data for age, serum and LDL cholesterol,
LDL protein and the indices of LDL oxidation are sum-
marized in table 1. LDL oxidation indices calculated
from sigmoidal fit to the LDL oxidation time course are
explained in figure 1. There were no marked differences
between men and women: slightly higher total serum
cholesterol, a shorter lag time and higher rate of LDL
oxidation were found in women than in men.
b) In our group we found about 6 percent of persons
with a very prolonged initial oxidation phase, mostly
longer than 240 min. No obvious association was found
with this phenomenon, except the fact that these individ-
uals exhibited very low total (mean 3.3, range 2.8—4.7
mmol/1) and LDL cholesterol concentration (mean 1.28,
range 0.8-2.0 mmol/1).
c) In contrast to average data of all men and women as
shown in table 1, the data of women over 50 years — the
menopausal age generally recognized as a risk factor of
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Tab. 1 Characteristics of examined group of men and women.
Variable
Age (years)
Total serum cholesterol (mmol/1)
LDL cholesterol (mmol/1)
Lag time (min)a
Half-time (min)b
Rate (μιηοΐ/ΐ · min)c
Oxidized LDL (Diene) (μιηοΐ/ΐ)0
All subjects
Ν = 104
38.7 ± 11.9
4.7 ± 0.9
2.9 ± 0.8
90.7 ± 58.4
143.6 ± 197.5
0.48 ± 0.1
22.8 ± 8.2
Men
N = 52
37.0 ±11.8
4.5 ± 1.0
2.8 ± 0.98
103.2 ± 71.7
179.2 ±241.1
0.43 ± 0.1
21.8 ± 9.4
Women
N = 52
40.2 ± 11.9
5.0 ± 0.9
3.0 ± 0.87
78.1 ± 37.7
107.9 ± 129.0
0.52 ± 0.2
23.7 ± 6.7
Ρ
ns
0.03
ns
0.03
ns
0.02
ns
Data expressed as means ± SD.
Data of oxidized LDL samples:
Mean protein concentration: 0.1 ±0.07 g per litre of isolated
LDL.
a
 Induction phase of LDL oxidation corresponding to 20 percent
of total net increase of absorbance (see "lag time" in fig. 1).
b
 Half-time (see fig. 1) of LDL oxidation.
c
 Maximum rate of absorbance change (see fig. 1) expressed in the
P = Significance between men and women (2-tailed t-test):
ns = not significant.
oxidized LDL (diene) production per litre of isolated LDL (corre-
sponding to 50 ml of serum) per min.
d
 Maximal increase of absorbance (see Final absorbance (FA)-
Initial absorbance (IA) in fig. 1) expressed as the conjugated diene
concentration per litre of isolated LDL (corresponding to 50 ml
of serum).
cardiovascular diseases — were higher in many variables
than those of younger women. This was not the case for
men. Among the LDL oxidation indices, total oxidation
was significantly higher in elderly women (tab. 2).
d) To investigate the association of another established
risk factor of atherosclerosis with the indices of LDL
oxidation in the same individual, the whole cohort was
stratified into lower and higher LDL cholesterol (i.e.
< 3.6 mmol/1 and > 3.6 mmol/1), corresponding to
lower or higher risk of atherosclerosis and comprising
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Fig. 1 LDL oxidation, showing fit to sigmoidal regression func-
tion and its first derivative.
The coefficients of the equation
y = (IA-FA)/(1 + exp(x-HT)/W) + FA
calculated by the least squares method (quasi-Newton) were:
absorbance before (LA) and at the end (FA) of LDL oxidation;
(FA—IA) = total LDL oxidation; lag time = induction phase of
LDL oxidation; half-time = time when half of the difference be-
tween initial and final absorbance has been reached; width = time
interval of fastest propagation phase. The symbols y and χ in the
equation stand for the data on the vertical and/or horizontal axis.
Maximum rate of propagation phase (MR) can be calculated ac-
cording to the formula: (y2—yi)/W, where yi = (IA—FA)/
(1 + exp(-O.S)) + FA, and y2 = (IA-FA)/(1 + exp(0.5))+FA. In
a simplified formula, maximum rate = [(IA—FA) χ — 0.245]/W.
(MR can also be assessed according to the peak of the first deriva-
tive of primitive function).
about 75% and 25% of all participants, respectively. The
average value of LDL cholesterol was 2.5 ± 0.6 and 4.2
± 0.42 mmol/1 in the lower risk and higher risk group,
respectively. As can be seen in table 3, these two groups
differed in age, serum total cholesterol and the extent of
LDL oxidation. They did not differ in half-time, lag time
or the oxidation rate. The tendency of half-time or lag
time to be shorter and the rate of oxidation to be higher
in the higher risk group was nevertheless evident and
these quantities were significantly different from those
in the bottom quartile (tab. 3).
Virtually the same results were obtained if stratification
was made according to lower and higher total serum
cholesterol (i. e. < 5.2 and > 5.2 mmol/1).
Correlation coefficients of LDL oxidation
indices versus age, LDL cholesterol and
LDL protein
The matrix of selected correlation coefficients between
LDL oxidation indices on the one hand, and age, total
Tab. 2 Cholesterol and indices of LDL oxidation. Effect of
menopausal state.
Variables Menopausal state
Age (years)
Total serum cholesterol
(mmol/1)
LDL cholesterol (mmol/1)
Lag time (min)
Half-time (min)
Rate (umol/1 · min)
Oxidized LDL (Diene)
(umol/1)
no
N = 36
35.8 ± 10.3
4.6 ± 0.74
2.7 ± 0.76
78.9 ± 41.8
113.5 ± 151.2
0.51 ± 0.20
22.3 ± 5.9
yes
N = 12
53.6 ± 3.4***
5.9 ± 0.82***
3.6 ± 0.98**
76.8 ± 27.3
95.2 ±31.9*
0.53 ± 0.2
28.1 ± 7.8**
Data expressed as means ± SD.
Statistical significance:
*** P < 0.0001; ** P < 0.01 (2-tailed t-test);
* P < 0.0001 (F-test). Otherwise see table 1.
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Tab. 3 Age, cholesterol and LDL oxidation indices in lower and
higher risk LDL cholesterol group.
Age (years)
Total serum cholesterol
(mmol/1)
LDL cholesterol
(mmol/1)
Oxidized LDL
(Diene) (μιηοΐ/ΐ)
Lag time
(min)
Half-time
(min)
Rate
(μιηοΐ/l · min)
Lower risk
group
36.4 ± 11.8
( N = 74)
4.4 ± 0.78
(N = 77)
2.5 ± 0.6
(N = 77)
20.1 ± 7.0
(N = 77)
94.1 ± 65.4
(N = 77)
156.9 ± 223.4
(N = 77)
0.45 ±0.18
(N = 72)
Higher risk
group
46.6 ± 8.6a
(N = 21)
5.9 ± 0.77a
(N = 23)
4.2 ± 0.42a
(N = 23)
31.8 ± 5.0a
(N = 23)
78.9 ± 18.3b
(N = 23)
98.8 ± 20.8b
(N = 23)
0.54±0.11b
(N = 23)
Data expressed as means ± SD.
Lower or higher risk group: LDL cholesterol < 3.6 mmol/1 or
> 3.6 mmol/1.
Lower quartile data: Lag time 118.8 ± 90.1; Half time 243.6
±319.4; Rate 0.42 ±0.21.
a
 Significant difference between lower and higher risk group.
b
 Significant difference between lower quartile data and higher
risk group.
Otherwise see table 1.
cholesterol, LDL cholesterol and LDL protein on the
other hand is demonstrated in table 4. The closed posi-
tive association was demonstrated between the extent of
LDL total oxidation and LDL cholesterol, as well as
between starting LDL absorbance and LDL protein. This
was true in both men and women. A negative associa-
tion of LDL cholesterol with LDL oxidative resistance
(half-time or lag time) was significant only in men.
Whereas LDL cholesterol (LDLc) was related linearly
to the extent of oxidation, it was related non-linearly to
the lag time (U-shaped curve) with the quadratic regres-
sion function: Lag time =353.7-167.1 X LDL-c
+ 23.9 X (LDL-c)2. Minimum lag time (calculated un-
der the condition that the first derivative equalled zero)
corresponded to 3.5 mmol/1 of LDL cholesterol (LDL-
c). The rate of LDL oxidation was significantly and pos-
itively associated with LDL cholesterol in both men
and women.
Multiple linear regression analysis of LDL
oxidation
Because the interrelation between the variables, as de-
monstrated in table 4, was not necessarily independent,
multivariate regression analysis was carried out. The re-
sults given in table 5 show that the extent of LDL total
oxidation was positively and most closely associated
with LDL cholesterol, less so with the rate of oxidation
and negatively associated with the lag time in both
sexes.
Logistic regression of age, gender and high
oxidized LDL
The abnormally high values of LDL oxidation were de-
fined by the data in the range of the upper quintile. The
relation between the incidence of high LDL oxidation
and age in men and women is depicted in figure 2.
Whereas the frequency of high oxidation increased mo-
notonously with age in men, this relation was complex
in women. In premenopausal age the frequency was
smaller than in men, but around menopausal age it
started to increase markedly and reached and/or ex-
ceeded the values of men. Using bivariate analysis, the
age-controlled frequency was higher in men than in
women within a younger age range (odds ratio 3.56,
95% confidence interval: 1.5-5.56) whereas after 50
years the frequency was virtually gender-independent
Tab. 4 Correlation coefficient matrix of age, total cholesterol, LDL cholesterol and LDL protein with
low-density lipoprotein oxidation indices in men and women.
Variable
Age (years)
Total serum cholesterol
Initial LDL
absorbance
Λ 1 cm
^234 nm
(J
0.45a
0.60a
?
ns
0.42b
Oxidized LDL
(Diene)
(μπιοΙ/1)
$
0.54a
0.75a
9
0.42b
0.67a
Half-Time
(min)
$ 9
ns ns
-0.42b ns
Lag Time
(min)
<? 9
ns ns
-0.37b ns
Rate
(μιηοΐ/ΐ
c?
0.32C
0.34C
• min)
9
ns
ns
(mmol/1)
LDL cholesterol
(mmol/1)
0.68a 0.43b 0.89a 0.69a -0.48a ns -0.473 ns 0.45b 0.27C
LDL cholesterol/protein
LDL protein
(g/0
ns
0.83a
ns
0.66a
0.93a*
ns
0.81a*
ns
-0.40b
ns
ns
ns
-0.43"
ns
ns
ns
0.72a**
ns
0.603**
ns
Data expressed as means ± SD.
ns = P not significant.
a
 P < 0.001; b P < 0.01; c P < 0.05.
* oxidized LDL (Diene) (nmol/mg protein).
** Rate (nmol/mg protein).
Otherwise see table 1.
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Tab. 5 Multiple regression analysis of LDL oxidation where oxidized LDL (Diene) is the dependent
variable.
All subjects:
Diene (μηιοΐ/ΐ)
Age (years)
LDL cholesterol (mmol/1)
LDL protein (g/1)
Lag time (min)
Rate (μηιοΐ/ΐ · min)
Men:
Diene (μηιοΐ/l)
Age (years)
LDL cholesterol (mmol/1)
LDL protein (g/1)
lag time (min)
Rate (μηιοΙ/1 · min)
Women:
Diene (μιηοΐ/l)
Age (years)
LDL cholesterol (mmol/1)
LDL protein (g/1)
Lag time (min)
Rate (μηιοΐ/ΐ · min)
Raw data
Partial
correlation
coefficient
0.22
0.69
0.18
-0.61
0.45
0.16
0.83
-0.03
-0.76
0.55
0.24
0.56
0.34
-0.47
0.43
P
0.04
<0.00001
ns
<0.00001
<0.00001
ns
<0.00001
ns
<0.00001
<0.0001
ns
<0.00001
0.02
<0.001
0.003
Diene*
Age (years)
LDL cholesterol*
LDL protein (g/1)
Lag time (min)
Rate*
Diene*
Age (years)
LDL cholesterol*
LDL protein (g/1)
Lag time (min)
Rate*
Diene*
Age (years)
LDL cholesterol*
LDL protein (g/1)
Lag time (min)
Rate*
Raw data
Partial
correlation
coefficient
0.03
0.85
0.32
-0.75
0.62
0.11
0.86
0.43
-0.87
0.71
0.13
0.85
0.38
-0.66
0.67
P
ns
<0.0001
<0.01
<0.0001
<0.0001
ns
<0.0001
<0.001
<0.0001
<0.0001
ns
<0.0001
<0.05
<0.0001
<0.0001
* Data normalized per protein unit.
P = statistical significance.
ns = not significant.
Otherwise see table 1.
(odds ratios 0.96, 95% confidence interval: —2.37—
4.28).
The mentioned likelihood development could be ex-
pressed in more detail using sigmoidal fit to probability
data. The time to reach a 20% frequency was 29.3 years
30 40
Age [years]
Fig. 2 Logistic function of the frequency of high concentrations
of oxidized LDL as related to age and/or the LDL cholesterol con-
centration.
Note that the difference between men and women is more marked
if the frequency is related to age rather than to LDL cholesterol.
The inserted picture demonstrates the changes of frequency with
age (first derivative of main picture curves). The different types of
changes between men and women, but exhibiting the peak at sim-
ilar age, are apparent.
in men and 47.5 years in women. The time to reach a
50% frequency was 55.5 years in men and 54.1 years in
women and maximum increase of frequency was 1.3%
per year in men and 5% per year in women.
The curves of instantaneous change of frequency (first
derivative) as demonstrated in the insert of figure 2
underline marked gender differences as affected by
age.
The incidence of high LDL oxidation as related to the
LDL cholesterol (in comparison with age) is included
in the same picture. There is small gender difference.
However, in the range of 3—4 mmol/1 of LDL choles-
terol there was a trend to a lower incidence of oxidation
in women than in men.
A similar processing of data for lag time and/or the rate
of LDL oxidation did not indicate that they are depen-
dent on age.
Discussion
The extent of LDL oxidation is thought to be largely
indicated by the amount of polyunsaturated fatty acids
in cholesterol esters, which serve as the oxidizable sub-
strate in the formation of conjugated diene. On the other
hand, the mechanism and/or the determinants of lag
time, half-time or oxidation rate are less clear (18-23).
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From table 1, an influence of gender either on the
average LDL composition or LDL oxidation indices is
hardly apparent.
However, after dividing the population sample into
younger and older men or women (i. e. pre- and meno-
pausal status), the effect of age was clearly gender-
dependent (tab. 2). LDL oxidation, together with total or
serum cholesterol fractions, was significantly higher in
older than in younger women. No significant differences
were found in men, however. As also indicated by the
next analysis, related increments of dependent variables
approach their maximum asymptotically in men around
the age of 50 years, but not in women.
The finding that the premenopausal state had a benefi-
cial effect on total oxidation but not on the resistance of
LDL oxidation (i.e. lag time or half-time) was unex-
pected. In several papers it has been shown that the ad-
ministration of a small amount of oestrogen increased
LDL oxidation resistance in in vitro as well as in ex
vivo experiments (24—26). The reason for our failure to
find this effect in our LDL samples of young women
could be accounted for by the fact that a supraphysiolog-
ical concentration of oestrogen was used in some of the
mentioned experimental work. In Sack's clinical study
(26) two groups of post-menopausal women, with and
without oestrogen administration, were compared; but in
contrast to the present work, Sack's study did not in-
clude a comparison of untreated pre- and post-meno-
pausal women.
The other explanation, i. e. that we included in our group
some elderly menopausal women with normal oestrogen
levels seems to be very unlikely. Major changes in
oestrogen occur in the immediate post-menopausal
period, with little subsequent change with age. In addi-
tion some recent papers seriously question any role of
endogenous oestrogen (in contrast to exogenous oestro-
gen) in coronary heart disease. Accordingly, this role
is more significantly associated with the age of women
(27, 28).
Nonetheless the possibility cannot be entirely excluded
that we removed part of the endogenous oestrogen dur-
ing isolation or by dilution of LDL. It is conceivable that
special precautions are needed during the isolation and
purification of LDL in order to see the effect of endoge-
nous oestrogens.
The stratification of all participants according to lower
and higher risk LDL cholesterol revealed that the extent
of LDL oxidation was greater in the latter group, but
there was no significant change in the half-time, lag time
and the rate of oxidation (tab. 3). The lack of signifi-
cance was probably due to the high standard deviation
of means resulting from the occurrence of several very
low susceptibility data associated with the low total and
LDL cholesterol. The initial oxidation phase of these
samples was much longer than expected from linear ex-
trapolation.
We observed a similar disproportionate prolongation of
lag time related to low LDL cholesterol levels in earlier
work on the oxidation of animal LDL (7), suggesting
that these two variables in general are related in a non-
linear fashion. Absence of preformed lipid hydroperox-
ides — an important determinant of the LDL oxidative
susceptibility — could be a likely explanation (21, 22).
Support for such a hypothesis was provided by the fact
that a trace amount of oxysterol added to the LDL prep-
arations was sufficient not only to restore normal oxida-
tion kinetics but in fact to eliminate completely the ini-
tial phase (not shown). Thus the possibility was ex-
cluded that these particular LDL samples were dam-
aged irreversibly.
The abnormally low level of cholesterol has been found
in other studies in about 3-6% of the Western popula-
tion, which is similar to the frequency found in the pre-
sent paper. The expression of recently identified apoli-
poprotein B mutations might be involved (29). The
problem of low cholesterolaemia is currently under con-
siderable debate because of its assumed association with
mental disorders (depression, suicides etc.) or cancer
(30—42). The association could not be confirmed or
ruled out in the present study because the relevant parti-
cipants were predominantly younger people (mean 30.8
years, range 21—45 years) and serious clinical manifes-
tation could appear a decade later (33). If the mentioned
non-cardiovascular diseases are causally linked to the
low cholesterolaemia, then the associated unusually high
resistance to oxidation of appropriate LDL as found in
this paper could partly contribute to the underlying
mechanism.
The correlation matrix (tab. 4) and multivariate regres-
sion analysis (tab. 5) showed that the maximum of LDL
oxidation was primarily related to the cholesterol
content in LDL and associated with the shortening of
lag time and the increase of oxidation rate. Bivariate
analysis showed that the greater the extent of total oxi-
dation, the shorter the initial phase and the greater the
oxidation rate.
Earlier epidemiological studies have shown repeatedly
(4—6) that the incidence of cardiovascular complica-
tions of atherosclerosis increase with the age of partici-
pants of both sexes. Because of the proposed involve-
ment of LDL oxidation in atherogenesis, the question
arose as to whether an analogous relation exists between
this variable and age. Logistic analysis showed that such
a correlation exists, and that the development of high
LDL oxidation occurs differently in men and women.
Whereas the frequency of high LDL oxidation increased
monotonously and steadily in men between the ages of
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20 and 70 years, younger women showed a very low
frequency, which then increased rapidly during the
menopause. The significance of the age factor decreased
dramatically if adjusted for LDL cholesterol.
The occurrence of abnormal susceptibility of LDL to
oxidation (abnormal lag time or oxidation rate) did not
increase with age.
All the mentioned facts strongly suggest that the
role of the age factor is largely related to LDL choles-
terol development. We recalculated other recently pub-
lished data (5) on age — related risk LDL cholesterol,
and found a very similar time course, as shown in
figure 2.
At the present time, there are increasing numbers of re-
ports indicating that resistance of LDL to oxidation (e. g.
following antioxidant administration) does not always
correlate satisfactorily to the development of atheroscle-
rosis, especially in cases of elevated cholesterol in serum
(43—50). It was also found that LDL of patients treated
with hypocholesterolaemic drugs contained lower LDL
cholesterol, accompanied by a decreased extent of oxi-
dation and no change in the oxidation lag phase (51).
These papers are in keeping with our results, suggesting
that the extent of LDL oxidation, related closely to cho-
lesterol content, and associated with oxidative kinetics,
represents an important risk factor for atherosclerosis
development.
In conclusion it should be noted, however, that in vivo
the quantity of oxidized LDL, as the ultimate and deci-
sive atherogenic determinant, results from a multifacto-
rial process. It is given not only by a complex time func-
tion of LDL concentration and size, lag time and the rate
of oxidation, but also by the net uptake of LDL and
decomposition rate of oxidized LDL.
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